Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN CSA ISO TS 16775-17: Guidance on Packaging for Terminally Sterilized Medical Devices
Scope, Technical Guidance, and Compliance Considerations for Canadian Adopters
Scope and Applicability
CAN CSA ISO TS 16775-17 is the Canadian adoption of ISO/TS 16775:2014 (with potential national modifications). It provides comprehensive guidance on the application of the ISO 11607 series—specifically ISO 11607-1 (requirements for packaging for terminally sterilized medical devices) and ISO 11607-2 (validation requirements for forming, sealing, and assembly processes). The Technical Specification is applicable to all organizations involved in the design, development, production, testing, and regulatory submission of packaging systems for medical devices that undergo terminal sterilization.
While ISO/TS 16775-17 itself is not a normative requirement, it is widely used by manufacturers, test laboratories, and regulatory authorities in Canada to interpret and implement the more prescriptive clauses of ISO 11607. The standard is particularly valuable for small and medium enterprises (SMEs) that need practical examples, statistical methods, and decision matrices for packaging validation.
Tip: CAN CSA ISO TS 16775-17 should be used together with the latest editions of ISO 11607-1 and ISO 11607-2. It does not replace those standards but clarifies their application in real-world scenarios.
Technical Requirements and Guidance
ISO/TS 16775-17 addresses key technical areas where the base standards require interpretation. The main guidance topics include:
- Material Performance: Selection of packaging materials that maintain microbial barrier properties, compatibility with sterilization methods, and physical integrity over the declared shelf life.
- Seal Integrity: Guidance on establishing sealing parameters (temperature, pressure, dwell time) and evaluating seal strength continuously and after aging.
- Microbial Barrier Testing: Clarification on test methods (e.g., ASTM F1608, ISO 5636-5) for porous materials and the use of the “bubble point” for non-porous films.
- Validation Protocols: Detailed examples of process validation for sealing, assembly, and package integrity testing, including the use of attribute and variable sampling plans.
- Accelerated and Real-Time Aging: Guidance based on ASTM F1980 for establishing the expiration date of sterile packages.
| Guidance Area | Key Recommendations from ISO/TS 16775-17 | Relevance to ISO 11607 |
|---|---|---|
| Sealing Process Validation | Use of challenge conditions (e.g., worst-case limits) and periodic revalidation after any significant change. | Supplements ISO 11607-2 §5.1 |
| Package Integrity Testing | Selection of test methods (dye penetration, bubble emission, vacuum leak) based on package type and permeability. | Supplements ISO 11607-1 §5.2 |
| Sample Size Rationale | Provides statistical rationale for non-parametric and parametric tests, including AQL and LTPD approaches. | Supplements ISO 11607-2 §5.2.2 |
| Microbial Barrier Assessment | Detailed test data analysis, including the use of marginal bacterial penetration (MBP) for porous materials. | Supplements ISO 11607-1 §5.1 |
Warning: The guidance in ISO/TS 16775-17 may not be directly applicable to specialty packages such as custom kits, implantable device trays, or packaging used in aseptic processing. Always perform a risk assessment to determine the adequacy of the guidance.
Implementation Highlights
Adoption of CAN CSA ISO TS 16775-17 within a quality management system (e.g., ISO 13485) involves several key steps:
- Gap Analysis: Compare current packaging practices against the guidance provided for each phase of product realization.
- Training: Ensure R&D, quality, and production teams understand the statistical methods and process validation examples.
- Documentation: Update packaging specifications, validation protocols, and standard operating procedures to reflect the recommended approaches.
- Testing: Implement routine monitoring plans with sampling frequencies aligned to the risk-based matrix in the Technical Specification.
One of the most practical contributions of ISO/TS 16775-17 is the inclusion of decision trees for selecting test methods based on package configuration (e.g., uncapped vs. capped tray, header bag vs. pouch). Manufacturers are advised to convert these decision trees into internal work instructions.
Success Story: Several Canadian medical device manufacturers have used the statistical sampling tables from Annex C of ISO/TS 16775-17 to reduce overall package testing costs by up to 30% while maintaining compliance with ISO 11607.
Non-compliance Risk: Failing to follow the guidance on seal validation (e.g., using only visual inspection instead of periodic integrity testing) has been cited in multiple Health Canada inspection reports as a contributing factor to sterile barrier breaches.
Compliance and Regulatory Notes
In Canada, CAN CSA ISO TS 16775-17 is a voluntary standard. However, Health Canada, under the Medical Devices Regulations (SOR/98-282), recognizes the ISO 11607 series as a “recognized standard” for demonstrating compliance with the sterility assurance requirements of Class II, III, and IV medical devices. The guidance offered by ISO/TS 16775-17 is often implicitly required by auditors because it clarifies the expected depth of documentation and validation.
Key compliance points for the Canadian market include:
- Customs harmonization – meeting the same guidance helps streamline market access to other ISO 11607-adopting territories (EU, Australia, Japan).
- Audit evidence – technical files should include references to the guidance clauses used when justifying design decisions; records of training on ISO/TS 16775-17 are also viewed favorably.
- Transition – if a previous Canadian standard (e.g., CSA Z314 series) was used, ISO/TS 16775-17 provides a migration path to the current global framework.
Q: Is CAN CSA ISO TS 16775-17 mandatory in Canada?
A: No, it is a voluntary guidance Technical Specification. However, it is widely referenced by regulatory auditors as the definitive interpretation of ISO 11607 for packaging.
A: No, it is a voluntary guidance Technical Specification. However, it is widely referenced by regulatory auditors as the definitive interpretation of ISO 11607 for packaging.
Q: How does this standard differ from the full ISO 11607 series?
A: ISO/TS 16775-17 provides explanatory text, examples, and statistical methods that are not included in ISO 11607-1 and ISO 11607-2, but it does not per se add new requirements.
A: ISO/TS 16775-17 provides explanatory text, examples, and statistical methods that are not included in ISO 11607-1 and ISO 11607-2, but it does not per se add new requirements.
Q: Can I use this guidance for U.S. FDA submissions?
A: The FDA recognizes ISO 11607-1 and -2 as consensus standards. The guidance in ISO/TS 16775-17 can be used to support the validation summary, but the specific statistical methods may require adaptation to FDA guidance documents.
A: The FDA recognizes ISO 11607-1 and -2 as consensus standards. The guidance in ISO/TS 16775-17 can be used to support the validation summary, but the specific statistical methods may require adaptation to FDA guidance documents.
© 2026 Technical Standards Publishing. This article provides general information about the standard and is not a substitute for the full text of CAN CSA ISO TS 16775-17.